The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

KU Hematology & Medical Oncology Review 2019
M

What Is CAR T-Cell Therapy? Overcoming Limitations of Current CARs, Review of Related Trials & Reasons for Treatment Failure

By KU Hematology & Medical Oncology Review 2019 FEATURING Marc Hoffmann
By KU Hematology & Medical Oncology Review 2019 FEATURING Marc Hoffmann
416 views
September 25, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
General
29:33
KU Hematology & Medical Oncology Review 2019

What Is CAR T-Cell Therapy? Overcoming Limitations of Current CARs, …

Feat. M. Hoffmann
25:46
KU Hematology & Medical Oncology Review 2019

KU ASCO 2019: New Drug Developments in Oncology: Change of How Drugs…

Feat. J. Baranda